PL3365327T3 - Sposób wytwarzania feksofenadyny i związki pośrednie stosowane w tym sposobie - Google Patents

Sposób wytwarzania feksofenadyny i związki pośrednie stosowane w tym sposobie

Info

Publication number
PL3365327T3
PL3365327T3 PL16784529T PL16784529T PL3365327T3 PL 3365327 T3 PL3365327 T3 PL 3365327T3 PL 16784529 T PL16784529 T PL 16784529T PL 16784529 T PL16784529 T PL 16784529T PL 3365327 T3 PL3365327 T3 PL 3365327T3
Authority
PL
Poland
Prior art keywords
fexofenadine
preparation
intermediates used
intermediates
Prior art date
Application number
PL16784529T
Other languages
English (en)
Inventor
Hermut Wehlan
Kai Rossen
Guenter Billen
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of PL3365327T3 publication Critical patent/PL3365327T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
PL16784529T 2015-10-22 2016-10-21 Sposób wytwarzania feksofenadyny i związki pośrednie stosowane w tym sposobie PL3365327T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15191020 2015-10-22
PCT/EP2016/075391 WO2017068129A1 (en) 2015-10-22 2016-10-21 Process for the preparation of fexofenadine and of intermediates used therein
EP16784529.6A EP3365327B1 (en) 2015-10-22 2016-10-21 Process for the preparation of fexofenadine and of intermediates used therein

Publications (1)

Publication Number Publication Date
PL3365327T3 true PL3365327T3 (pl) 2020-05-18

Family

ID=54360053

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16784529T PL3365327T3 (pl) 2015-10-22 2016-10-21 Sposób wytwarzania feksofenadyny i związki pośrednie stosowane w tym sposobie

Country Status (12)

Country Link
US (1) US10696633B2 (pl)
EP (1) EP3365327B1 (pl)
CN (1) CN109071438B (pl)
CA (1) CA3002425C (pl)
DK (1) DK3365327T3 (pl)
ES (1) ES2770341T3 (pl)
HR (1) HRP20200106T1 (pl)
HU (1) HUE047669T2 (pl)
PL (1) PL3365327T3 (pl)
PT (1) PT3365327T (pl)
RS (1) RS59874B1 (pl)
WO (1) WO2017068129A1 (pl)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2804422A (en) 1954-12-29 1957-08-27 Wm S Merrell Co Tranquilizing composition comprising alpha phenyl, alpha-(4-piperidyl)-benzyl alcohol and method of using same
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
WO1995000482A1 (en) 1993-06-24 1995-01-05 Albany Molecular Research, Inc. Piperidine derivatives and process for their production
CN1159277C (zh) 1993-06-25 2004-07-28 默里尔药物公司 用于制备抗组胺哌啶衍生物的新中间体
GB0018691D0 (en) * 2000-07-28 2000-09-20 Rolabo Sl Process
US6743941B2 (en) 2001-06-15 2004-06-01 Aventis Pharma Deutschland Gmbh Process for the production of piperidine derivatives
SK712003A3 (en) 2001-06-25 2003-12-02 Aurobindo Pharma Ltd Process for the preparation of 4-(cyclopropylcarbonyl)-alpha, alpha-dimethylphenylacetic acid
US7498345B2 (en) 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
WO2007135693A2 (en) 2006-05-18 2007-11-29 Ind-Swift Laboratories Limited Intermediates useful for the preparation of antihistaminic piperidine derivative
HUE044642T2 (hu) * 2015-01-22 2019-11-28 Sanofi Aventis Deutschland Eljárás 2-[4-(ciklopropánkarbonil)fenil]-2-metil-propánnitril elõállítására

Also Published As

Publication number Publication date
ES2770341T3 (es) 2020-07-01
DK3365327T3 (da) 2020-02-24
EP3365327B1 (en) 2019-11-20
US10696633B2 (en) 2020-06-30
HRP20200106T1 (hr) 2020-04-03
EP3365327A1 (en) 2018-08-29
CN109071438A (zh) 2018-12-21
CN109071438B (zh) 2023-02-21
CA3002425A1 (en) 2017-04-27
WO2017068129A1 (en) 2017-04-27
PT3365327T (pt) 2020-02-06
CA3002425C (en) 2023-10-17
US20180297951A1 (en) 2018-10-18
RS59874B1 (sr) 2020-03-31
HUE047669T2 (hu) 2020-05-28

Similar Documents

Publication Publication Date Title
SI3380530T1 (sl) Izboljšan postopek za pripravo sugamadeksa in njegovih intermediatov
IL287140A (en) A process for the preparation of polyethylene glycol-converted pharmaceutical binders and their intermediates
ZA201706795B (en) Process for the preparation of dicycloplatin
HK1254367A1 (zh) 新的工藝和中間體
IL274142A (en) A process for the preparation of sanicriviroc and related analogs
EP3212620A4 (en) Process for the preparation of apixaban and intermediates thereof
IL248267A0 (en) A process for preparing converted cycloserines
ZA202003590B (en) Process for the preparation of opicapone and intermediates thereof
HRP20190403T1 (hr) Postupak izrade lakozamida
IL272670A (en) Preparation of micro-electrodes
IL255819A (en) An improved process for the preparation of sofosbuvir and intermediates
HUP1400543A2 (hu) Eljárás és köztitermék apixaban elõállítására
IL253077A0 (en) Process and intermediates for the preparation of Fermpanel
ZA201701973B (en) Process for the preparation of halo-substituted trifluoroacetophenones
HUP1500647A2 (en) Intermediate of baricitinib and process for its preparation
IL237572A0 (en) Process and intermediates for the preparation of dastinib
ZA201608823B (en) Processes for the preparation of azd5363 and novel intermediate used therein
IL247443B (en) Process for the preparation of 5-fluorotryptophol
RS59874B1 (sr) Proces za pripremu feksofenadina i njegovih intermedijara
PL3230268T3 (pl) Sposób wytwarzania tetrakonazolu